Spyre Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Spyre Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2024.
  • Spyre Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 45.3M shares, a 1085% increase year-over-year.
  • Spyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.9M shares, a 105% increase from 2022.
  • Spyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.37M shares, a 28.2% increase from 2021.
  • Spyre Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 2.63M shares, a 95.1% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 45.3M +41.5M +1085% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 36.5M +32.7M +868% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 6.9M +3.53M +105% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 4.29M +526K +14% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 3.82M -78.4M -95.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 3.77M -62.2M -94.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 3.37M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 3.77M -62M -94.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 82.2M +16.6M +25.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 66M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 65.8M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 65.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.